APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mesalazine API

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Mesalazine API Industry Growth and Trends Forecast to 2032

28 December 2025104 pages

Choose your research edition.

Industry ResearchMesalazine API Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Mesalazine API Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Mesalazine API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mesalazine API Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Mesalazine API Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Mesalazine API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Mesalazine API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Mesalazine API is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mesalazine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mesalazine API include YC Biotech (Jiangsu), Lianyungang Fengheng Biopharm, Hangzhou Brother, Syntese A/S, PharmaZell, Lasa Loboratory, Ishita Active Pharma Ingredients, Ipca Laboratories and Erregierre SpA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Mesalazine API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Mesalazine API market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Mesalazine API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Mesalazine API.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Mesalazine API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Mesalazine API Market by Company

YC Biotech (Jiangsu)

Lianyungang Fengheng Biopharm

Hangzhou Brother

Syntese A/S

PharmaZell

Lasa Loboratory

Ishita Active Pharma Ingredients

Ipca Laboratories

Erregierre SpA

Divis Laboratories

CTX Lifescience

Corden Pharma Bergamo

Chemi SpA

Cambrex Corporation

Mesalazine API Segment by Type

Purity ≥ 99%

Purity ≥ 98%

Purity ≥ 97%

Mesalazine API Segment by Application

Suppository

Tablets

Granule

Capsules

Enema

Others

Mesalazine API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesalazine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mesalazine API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesalazine API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mesalazine API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Mesalazine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Purity ≥ 99% Table 2. Major Company of Purity ≥ 98% Table 3. Major Company of Purity ≥ 97% Table 4. Global Mesalazine API Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Mesalazine API Sales by Type (2021-2026) & (t) Table 6. Global Mesalazine API Sales Market Share in Volume by Type (2021-2026) Table 7. Global Mesalazine API Sales by Type (2021-2026) & (US$ Million) Table 8. Global Mesalazine API Sales Market Share in Value by Type (2021-2026) Table 9. Global Mesalazine API Price by Type (2021-2026) & (USD/kg) Table 10. Global Mesalazine API Sales by Type (2027-2032) & (t) Table 11. Global Mesalazine API Sales Market Share in Volume by Type (2027-2032) Table 12. Global Mesalazine API Sales by Type (2027-2032) & (US$ Million) Table 13. Global Mesalazine API Sales Market Share in Value by Type (2027-2032) Table 14. Global Mesalazine API Price by Type (2027-2032) & (USD/kg) Table 15. North America Mesalazine API Sales by Type (2021-2026) & (t) Table 16. North America Mesalazine API Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Mesalazine API Sales by Type (2021-2026) & (t) Table 18. Europe Mesalazine API Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Mesalazine API Sales by Type (2021-2026) & (t) Table 20. Asia-Pacific Mesalazine API Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Mesalazine API Sales by Type (2021-2026) & (t) Table 22. Latin America Mesalazine API Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Mesalazine API Sales by Type (2021-2026) & (t) Table 24. Middle East and Africa Mesalazine API Sales by Type (2021-2026) & (US$ Million) Table 25. Mesalazine API Industry Trends Table 26. Mesalazine API Industry Drivers Table 27. Mesalazine API Industry Opportunities and Challenges Table 28. Mesalazine API Industry Restraints Table 29. Global Mesalazine API Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Mesalazine API Revenue Market Share by Company (2021-2026) Table 31. Global Mesalazine API Sales by Company (2021-2026) & (t) Table 32. Global Mesalazine API Sales Share by Company (2021-2026) Table 33. Global Mesalazine API Market Price by Company (2021-2026) & (USD/kg) Table 34. Global Mesalazine API Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Mesalazine API Major Company Production Sites and Headquarters Table 36. Global Mesalazine API Company, Product Type & Application Table 37. Global Mesalazine API Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Mesalazine API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Mesalazine API Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Mesalazine API Sales by Region (2021-2026) & (t) Table 42. Global Mesalazine API Sales Market Share in Volume by Region (2021-2026) Table 43. Global Mesalazine API Sales by Region (2021-2026) & (US$ Million) Table 44. Global Mesalazine API Sales Market Share in Value by Region (2021-2026) Table 45. Global Mesalazine API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 46. Global Mesalazine API Sales by Region (2027-2032) & (t) Table 47. Global Mesalazine API Sales Market Share in Volume by Region (2027-2032) Table 48. Global Mesalazine API Sales by Region (2027-2032) & (US$ Million) Table 49. Global Mesalazine API Sales Market Share in Value by Region (2027-2032) Table 50. Global Mesalazine API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2027-2032) Table 51. Global Mesalazine API Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Mesalazine API Sales by Application (2021-2026) & (t) Table 53. Global Mesalazine API Sales Market Share in Volume by Application (2021-2026) Table 54. Global Mesalazine API Sales by Application (2021-2026) & (US$ Million) Table 55. Global Mesalazine API Sales Market Share in Value by Application (2021-2026) Table 56. Global Mesalazine API Price by Application (2021-2026) & (USD/kg) Table 57. Global Mesalazine API Sales by Application (2027-2032) & (t) Table 58. Global Mesalazine API Sales Market Share in Volume by Application (2027-2032) Table 59. Global Mesalazine API Sales by Application (2027-2032) & (US$ Million) Table 60. Global Mesalazine API Sales Market Share in Value by Application (2027-2032) Table 61. Global Mesalazine API Price by Application (2027-2032) & (USD/kg) Table 62. North America Mesalazine API Sales by Application (2021-2026) & (t) Table 63. North America Mesalazine API Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Mesalazine API Sales by Application (2021-2026) & (t) Table 65. Europe Mesalazine API Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Mesalazine API Sales by Application (2021-2026) & (t) Table 67. Asia-Pacific Mesalazine API Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Mesalazine API Sales by Application (2021-2026) & (t) Table 69. Latin America Mesalazine API Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Mesalazine API Sales by Application (2021-2026) & (t) Table 71. Middle East and Africa Mesalazine API Sales by Application (2021-2026) & (US$ Million) Table 72. YC Biotech (Jiangsu) Company Information Table 73. YC Biotech (Jiangsu) Business Overview Table 74. YC Biotech (Jiangsu) Mesalazine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 75. YC Biotech (Jiangsu) Mesalazine API Product Portfolio Table 76. YC Biotech (Jiangsu) Recent Development Table 77. Lianyungang Fengheng Biopharm Company Information Table 78. Lianyungang Fengheng Biopharm Business Overview Table 79. Lianyungang Fengheng Biopharm Mesalazine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 80. Lianyungang Fengheng Biopharm Mesalazine API Product Portfolio Table 81. Lianyungang Fengheng Biopharm Recent Development Table 82. Hangzhou Brother Company Information Table 83. Hangzhou Brother Business Overview Table 84. Hangzhou Brother Mesalazine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 85. Hangzhou Brother Mesalazine API Product Portfolio Table 86. Hangzhou Brother Recent Development Table 87. Syntese A/S Company Information Table 88. Syntese A/S Business Overview Table 89. Syntese A/S Mesalazine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 90. Syntese A/S Mesalazine API Product Portfolio Table 91. Syntese A/S Recent Development Table 92. PharmaZell Company Information Table 93. PharmaZell Business Overview Table 94. PharmaZell Mesalazine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 95. PharmaZell Mesalazine API Product Portfolio Table 96. PharmaZell Recent Development Table 97. Lasa Loboratory Company Information Table 98. Lasa Loboratory Business Overview Table 99. Lasa Loboratory Mesalazine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 100. Lasa Loboratory Mesalazine API Product Portfolio Table 101. Lasa Loboratory Recent Development Table 102. Ishita Active Pharma Ingredients Company Information Table 103. Ishita Active Pharma Ingredients Business Overview Table 104. Ishita Active Pharma Ingredients Mesalazine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 105. Ishita Active Pharma Ingredients Mesalazine API Product Portfolio Table 106. Ishita Active Pharma Ingredients Recent Development Table 107. Ipca Laboratories Company Information Table 108. Ipca Laboratories Business Overview Table 109. Ipca Laboratories Mesalazine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 110. Ipca Laboratories Mesalazine API Product Portfolio Table 111. Ipca Laboratories Recent Development Table 112. Erregierre SpA Company Information Table 113. Erregierre SpA Business Overview Table 114. Erregierre SpA Mesalazine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 115. Erregierre SpA Mesalazine API Product Portfolio Table 116. Erregierre SpA Recent Development Table 117. Divis Laboratories Company Information Table 118. Divis Laboratories Business Overview Table 119. Divis Laboratories Mesalazine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 120. Divis Laboratories Mesalazine API Product Portfolio Table 121. Divis Laboratories Recent Development Table 122. CTX Lifescience Company Information Table 123. CTX Lifescience Business Overview Table 124. CTX Lifescience Mesalazine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 125. CTX Lifescience Mesalazine API Product Portfolio Table 126. CTX Lifescience Recent Development Table 127. Corden Pharma Bergamo Company Information Table 128. Corden Pharma Bergamo Business Overview Table 129. Corden Pharma Bergamo Mesalazine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 130. Corden Pharma Bergamo Mesalazine API Product Portfolio Table 131. Corden Pharma Bergamo Recent Development Table 132. Chemi SpA Company Information Table 133. Chemi SpA Business Overview Table 134. Chemi SpA Mesalazine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 135. Chemi SpA Mesalazine API Product Portfolio Table 136. Chemi SpA Recent Development Table 137. Cambrex Corporation Company Information Table 138. Cambrex Corporation Business Overview Table 139. Cambrex Corporation Mesalazine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 140. Cambrex Corporation Mesalazine API Product Portfolio Table 141. Cambrex Corporation Recent Development Table 142. North America Mesalazine API Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 143. North America Mesalazine API Sales by Country (2021-2026) & (t) Table 144. North America Mesalazine API Sales Market Share by Country (2021-2026) Table 145. North America Mesalazine API Sales Forecast by Country (2027-2032) & (t) Table 146. North America Mesalazine API Sales Market Share Forecast by Country (2027-2032) Table 147. North America Mesalazine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. North America Mesalazine API Market Size by Country (2021-2026) & (US$ Million) Table 149. North America Mesalazine API Market Share by Country (2021-2026) Table 150. North America Mesalazine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. North America Mesalazine API Market Share Forecast by Country (2027-2032) Table 152. Europe Mesalazine API Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 153. Europe Mesalazine API Sales by Country (2021-2026) & (t) Table 154. Europe Mesalazine API Sales Market Share by Country (2021-2026) Table 155. Europe Mesalazine API Sales Forecast by Country (2027-2032) & (t) Table 156. Europe Mesalazine API Sales Market Share Forecast by Country (2027-2032) Table 157. Europe Mesalazine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Europe Mesalazine API Market Size by Country (2021-2026) & (US$ Million) Table 159. Europe Mesalazine API Market Share by Country (2021-2026) Table 160. Europe Mesalazine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Europe Mesalazine API Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Mesalazine API Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Mesalazine API Sales by Country (2021-2026) & (t) Table 164. Asia-Pacific Mesalazine API Sales Market Share by Country (2021-2026) Table 165. Asia-Pacific Mesalazine API Sales Forecast by Country (2027-2032) & (t) Table 166. Asia-Pacific Mesalazine API Sales Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Mesalazine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Mesalazine API Market Size by Country (2021-2026) & (US$ Million) Table 169. Asia-Pacific Mesalazine API Market Share by Country (2021-2026) Table 170. Asia-Pacific Mesalazine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Asia-Pacific Mesalazine API Market Share Forecast by Country (2027-2032) Table 172. Latin America Mesalazine API Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 173. Latin America Mesalazine API Sales by Country (2021-2026) & (t) Table 174. Latin America Mesalazine API Sales Market Share by Country (2021-2026) Table 175. Latin America Mesalazine API Sales Forecast by Country (2027-2032) & (t) Table 176. Latin America Mesalazine API Sales Market Share Forecast by Country (2027-2032) Table 177. Latin America Mesalazine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Latin America Mesalazine API Market Size by Country (2021-2026) & (US$ Million) Table 179. Latin America Mesalazine API Market Share by Country (2021-2026) Table 180. Latin America Mesalazine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Latin America Mesalazine API Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Mesalazine API Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Mesalazine API Sales by Country (2021-2026) & (t) Table 184. Middle East and Africa Mesalazine API Sales Market Share by Country (2021-2026) Table 185. Middle East and Africa Mesalazine API Sales Forecast by Country (2027-2032) & (t) Table 186. Middle East and Africa Mesalazine API Sales Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Mesalazine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Mesalazine API Market Size by Country (2021-2026) & (US$ Million) Table 189. Middle East and Africa Mesalazine API Market Share by Country (2021-2026) Table 190. Middle East and Africa Mesalazine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Middle East and Africa Mesalazine API Market Share Forecast by Country (2027-2032) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Mesalazine API Distributors List Table 195. Mesalazine API Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Mesalazine API Image Figure 2. Global Mesalazine API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mesalazine API Market Size (2021-2032) & (US$ Million) Figure 4. Global Mesalazine API Sales (2021-2032) & (t) Figure 5. Purity ≥ 99% Image Figure 6. Global Purity ≥ 99% Sales YoY Growth (2021-2032) & (t) Figure 7. Purity ≥ 98% Image Figure 8. Global Purity ≥ 98% Sales YoY Growth (2021-2032) & (t) Figure 9. Purity ≥ 97% Image Figure 10. Global Purity ≥ 97% Sales YoY Growth (2021-2032) & (t) Figure 11. Global Mesalazine API Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Mesalazine API Market Share by Type 2025 VS 2032 Figure 13. North America Mesalazine API Sales Market Share in Volume by Type in 2025 Figure 14. North America Mesalazine API Sales Market Share in Value by Type in 2025 Figure 15. Europe Mesalazine API Sales Market Share in Volume by Type in 2025 Figure 16. Europe Mesalazine API Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Mesalazine API Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Mesalazine API Sales Market Share in Value by Type in 2025 Figure 19. Latin America Mesalazine API Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Mesalazine API Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Mesalazine API Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Mesalazine API Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Mesalazine API Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Suppository Image Figure 26. Global Suppository Sales YoY Growth (2021-2032) & (t) Figure 27. Tablets Image Figure 28. Global Tablets Sales YoY Growth (2021-2032) & (t) Figure 29. Granule Image Figure 30. Global Granule Sales YoY Growth (2021-2032) & (t) Figure 31. Capsules Image Figure 32. Global Capsules Sales YoY Growth (2021-2032) & (t) Figure 33. Enema Image Figure 34. Global Enema Sales YoY Growth (2021-2032) & (t) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (t) Figure 37. Global Mesalazine API Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Mesalazine API Market Share by Application 2025 VS 2032 Figure 39. North America Mesalazine API Sales Market Share in Volume by Application in 2025 Figure 40. North America Mesalazine API Sales Market Share in Value by Application in 2025 Figure 41. Europe Mesalazine API Sales Market Share in Volume by Application in 2025 Figure 42. Europe Mesalazine API Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Mesalazine API Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Mesalazine API Sales Market Share in Value by Application in 2025 Figure 45. Latin America Mesalazine API Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Mesalazine API Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Mesalazine API Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Mesalazine API Sales Market Share in Value by Application in 2025 Figure 49. North America Mesalazine API Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 50. North America Mesalazine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Mesalazine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Mesalazine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Mesalazine API Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 54. Europe Mesalazine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Mesalazine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Mesalazine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Mesalazine API Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 58. Asia-Pacific Mesalazine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Mesalazine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Mesalazine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Mesalazine API Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 62. Latin America Mesalazine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Mesalazine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Mesalazine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Mesalazine API Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 66. Middle East and Africa Mesalazine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Mesalazine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Mesalazine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Mesalazine API Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Mesalazine API Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Purity ≥ 99%
  • Purity ≥ 98%
  • Purity ≥ 97%
Applications
  • Suppository
  • Tablets
  • Granule
  • Capsules
  • Enema
  • Others
Companies covered
  • YC Biotech (Jiangsu)
  • Lianyungang Fengheng Biopharm
  • Hangzhou Brother
  • Syntese A/S
  • PharmaZell
  • Lasa Loboratory
  • Ishita Active Pharma Ingredients
  • Ipca Laboratories
  • Erregierre SpA
  • Divis Laboratories
  • CTX Lifescience
  • Corden Pharma Bergamo
  • Chemi SpA
  • Cambrex Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mesalazine API Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Mesalazine API Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Mesalazine API Market by Type
  6. 1.3.1 Purity ≥ 99%
  7. 1.3.2 Purity ≥ 98%
  8. 1.3.3 Purity ≥ 97%
  9. 1.4 Global Mesalazine API Market Size by Type
  10. 1.4.1 Global Mesalazine API Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Mesalazine API Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Mesalazine API Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Mesalazine API Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Mesalazine API Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Mesalazine API Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Mesalazine API Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Mesalazine API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Mesalazine API Industry Trends
  2. 2.2 Mesalazine API Industry Drivers
  3. 2.3 Mesalazine API Industry Opportunities and Challenges
  4. 2.4 Mesalazine API Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Mesalazine API Revenue (2021-2026)
  2. 3.2 Global Top Players by Mesalazine API Sales (2021-2026)
  3. 3.3 Global Top Players by Mesalazine API Price (2021-2026)
  4. 3.4 Global Mesalazine API Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mesalazine API Major Company Production Sites & Headquarters
  6. 3.6 Global Mesalazine API Company, Product Type & Application
  7. 3.7 Global Mesalazine API Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mesalazine API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mesalazine API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mesalazine API Tier 1, Tier 2, and Tier 3
4 Mesalazine API Regional Status and Outlook
  1. 4.1 Global Mesalazine API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Mesalazine API Historic Market Size by Region
  3. 4.2.1 Global Mesalazine API Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Mesalazine API Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Mesalazine API Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Mesalazine API Forecasted Market Size by Region
  7. 4.3.1 Global Mesalazine API Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Mesalazine API Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Mesalazine API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Mesalazine API by Application
  1. 5.1 Mesalazine API Market by Application
  2. 5.1.1 Suppository
  3. 5.1.2 Tablets
  4. 5.1.3 Granule
  5. 5.1.4 Capsules
  6. 5.1.5 Enema
  7. 5.1.6 Others
  8. 5.2 Global Mesalazine API Market Size by Application
  9. 5.2.1 Global Mesalazine API Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global Mesalazine API Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global Mesalazine API Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America Mesalazine API Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe Mesalazine API Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific Mesalazine API Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America Mesalazine API Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa Mesalazine API Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 YC Biotech (Jiangsu)
  2. 6.1.1 YC Biotech (Jiangsu) Company Information
  3. 6.1.2 YC Biotech (Jiangsu) Business Overview
  4. 6.1.3 YC Biotech (Jiangsu) Mesalazine API Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 YC Biotech (Jiangsu) Mesalazine API Product Portfolio
  6. 6.1.5 YC Biotech (Jiangsu) Recent Developments
  7. 6.2 Lianyungang Fengheng Biopharm
  8. 6.2.1 Lianyungang Fengheng Biopharm Company Information
  9. 6.2.2 Lianyungang Fengheng Biopharm Business Overview
  10. 6.2.3 Lianyungang Fengheng Biopharm Mesalazine API Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Lianyungang Fengheng Biopharm Mesalazine API Product Portfolio
  12. 6.2.5 Lianyungang Fengheng Biopharm Recent Developments
  13. 6.3 Hangzhou Brother
  14. 6.3.1 Hangzhou Brother Company Information
  15. 6.3.2 Hangzhou Brother Business Overview
  16. 6.3.3 Hangzhou Brother Mesalazine API Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hangzhou Brother Mesalazine API Product Portfolio
  18. 6.3.5 Hangzhou Brother Recent Developments
  19. 6.4 Syntese A/S
  20. 6.4.1 Syntese A/S Company Information
  21. 6.4.2 Syntese A/S Business Overview
  22. 6.4.3 Syntese A/S Mesalazine API Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Syntese A/S Mesalazine API Product Portfolio
  24. 6.4.5 Syntese A/S Recent Developments
  25. 6.5 PharmaZell
  26. 6.5.1 PharmaZell Company Information
  27. 6.5.2 PharmaZell Business Overview
  28. 6.5.3 PharmaZell Mesalazine API Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 PharmaZell Mesalazine API Product Portfolio
  30. 6.5.5 PharmaZell Recent Developments
  31. 6.6 Lasa Loboratory
  32. 6.6.1 Lasa Loboratory Company Information
  33. 6.6.2 Lasa Loboratory Business Overview
  34. 6.6.3 Lasa Loboratory Mesalazine API Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Lasa Loboratory Mesalazine API Product Portfolio
  36. 6.6.5 Lasa Loboratory Recent Developments
  37. 6.7 Ishita Active Pharma Ingredients
  38. 6.7.1 Ishita Active Pharma Ingredients Company Information
  39. 6.7.2 Ishita Active Pharma Ingredients Business Overview
  40. 6.7.3 Ishita Active Pharma Ingredients Mesalazine API Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Ishita Active Pharma Ingredients Mesalazine API Product Portfolio
  42. 6.7.5 Ishita Active Pharma Ingredients Recent Developments
  43. 6.8 Ipca Laboratories
  44. 6.8.1 Ipca Laboratories Company Information
  45. 6.8.2 Ipca Laboratories Business Overview
  46. 6.8.3 Ipca Laboratories Mesalazine API Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Ipca Laboratories Mesalazine API Product Portfolio
  48. 6.8.5 Ipca Laboratories Recent Developments
  49. 6.9 Erregierre SpA
  50. 6.9.1 Erregierre SpA Company Information
  51. 6.9.2 Erregierre SpA Business Overview
  52. 6.9.3 Erregierre SpA Mesalazine API Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Erregierre SpA Mesalazine API Product Portfolio
  54. 6.9.5 Erregierre SpA Recent Developments
  55. 6.10 Divis Laboratories
  56. 6.10.1 Divis Laboratories Company Information
  57. 6.10.2 Divis Laboratories Business Overview
  58. 6.10.3 Divis Laboratories Mesalazine API Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Divis Laboratories Mesalazine API Product Portfolio
  60. 6.10.5 Divis Laboratories Recent Developments
  61. 6.11 CTX Lifescience
  62. 6.11.1 CTX Lifescience Company Information
  63. 6.11.2 CTX Lifescience Business Overview
  64. 6.11.3 CTX Lifescience Mesalazine API Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 CTX Lifescience Mesalazine API Product Portfolio
  66. 6.11.5 CTX Lifescience Recent Developments
  67. 6.12 Corden Pharma Bergamo
  68. 6.12.1 Corden Pharma Bergamo Company Information
  69. 6.12.2 Corden Pharma Bergamo Business Overview
  70. 6.12.3 Corden Pharma Bergamo Mesalazine API Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Corden Pharma Bergamo Mesalazine API Product Portfolio
  72. 6.12.5 Corden Pharma Bergamo Recent Developments
  73. 6.13 Chemi SpA
  74. 6.13.1 Chemi SpA Company Information
  75. 6.13.2 Chemi SpA Business Overview
  76. 6.13.3 Chemi SpA Mesalazine API Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Chemi SpA Mesalazine API Product Portfolio
  78. 6.13.5 Chemi SpA Recent Developments
  79. 6.14 Cambrex Corporation
  80. 6.14.1 Cambrex Corporation Company Information
  81. 6.14.2 Cambrex Corporation Business Overview
  82. 6.14.3 Cambrex Corporation Mesalazine API Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Cambrex Corporation Mesalazine API Product Portfolio
  84. 6.14.5 Cambrex Corporation Recent Developments
7 North America by Country
  1. 7.1 North America Mesalazine API Sales by Country
  2. 7.1.1 North America Mesalazine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Mesalazine API Sales by Country (2021-2026)
  4. 7.1.3 North America Mesalazine API Sales Forecast by Country (2027-2032)
  5. 7.2 North America Mesalazine API Market Size by Country
  6. 7.2.1 North America Mesalazine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Mesalazine API Market Size by Country (2021-2026)
  8. 7.2.3 North America Mesalazine API Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Mesalazine API Sales by Country
  2. 8.1.1 Europe Mesalazine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Mesalazine API Sales by Country (2021-2026)
  4. 8.1.3 Europe Mesalazine API Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Mesalazine API Market Size by Country
  6. 8.2.1 Europe Mesalazine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Mesalazine API Market Size by Country (2021-2026)
  8. 8.2.3 Europe Mesalazine API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Mesalazine API Sales by Country
  2. 9.1.1 Asia-Pacific Mesalazine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Mesalazine API Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Mesalazine API Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Mesalazine API Market Size by Country
  6. 9.2.1 Asia-Pacific Mesalazine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Mesalazine API Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Mesalazine API Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Mesalazine API Sales by Country
  2. 10.1.1 South America Mesalazine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Mesalazine API Sales by Country (2021-2026)
  4. 10.1.3 South America Mesalazine API Sales Forecast by Country (2027-2032)
  5. 10.2 South America Mesalazine API Market Size by Country
  6. 10.2.1 South America Mesalazine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Mesalazine API Market Size by Country (2021-2026)
  8. 10.2.3 South America Mesalazine API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Mesalazine API Sales by Country
  2. 11.1.1 Middle East and Africa Mesalazine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Mesalazine API Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Mesalazine API Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Mesalazine API Market Size by Country
  6. 11.2.1 Middle East and Africa Mesalazine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Mesalazine API Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Mesalazine API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Mesalazine API Value Chain Analysis
  2. 12.1.1 Mesalazine API Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Mesalazine API Production Mode & Process
  7. 12.2 Mesalazine API Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Mesalazine API Distributors
  10. 12.2.3 Mesalazine API Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst